Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 44-47, January 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suganuma, M.
Right arrow Articles by Fujiki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suganuma, M.
Right arrow Articles by Fujiki, H.
[Cancer Research 59, 44-47, January 1, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Synergistic Effects of (-)-Epigallocatechin Gallate with (-)-Epicatechin, Sulindac, or Tamoxifen on Cancer-preventive Activity in the Human Lung CancerCell Line PC-91

Masami Suganuma, Sachiko Okabe, Yasuko Kai, Naoko Sueoka2, Eisaburo Sueoka and Hirota Fujiki3

Saitama Cancer Center Research Institute, Saitama 362-0806, Japan

The study on incorporation of [3H](-)-epigallocatechin gallate (EGCG) into human lung cancer cell line PC-9 indicated that the [3H]EGCG incorporation was significantly enhanced by (-)-epicatechin, an inert tea polyphenol without a galloyl moiety. (-)-Epicatechin enhanced apoptosis, growth inhibition of PC-9 cells, and inhibition of tumor necrosis factor-{alpha} release from BALB/c-3T3 cells by EGCG and other tea polyphenols with a galloyl moiety in a dose-dependent manner. Moreover, the effects of EGCG on induction of apoptosis were also synergistically enhanced by other cancer-preventive agents, such as sulindac and tamoxifen. This paper reports significant evidence that whole green tea is a more reasonable mixture of tea polyphenols for cancer prevention in humans than EGCG alone and that it is even more effective when it is used in combination with other cancer preventives.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
C. D. Davis
Nutritional Interactions: Credentialing of Molecular Targets for Cancer Prevention
Experimental Biology and Medicine, February 1, 2007; 232(2): 176 - 183.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. H. Dashwood
Frontiers in Polyphenols and Cancer Prevention
J. Nutr., January 1, 2007; 137(1): 267S - 269S.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
M. R. Sartippour, R. Pietras, D. C. Marquez-Garban, H.-W. Chen, D. Heber, S. M. Henning, G. Sartippour, L. Zhang, M. Lu, O. Weinberg, et al.
The combination of green tea and tamoxifen is effective against breast cancer
Carcinogenesis, December 1, 2006; 27(12): 2424 - 2433.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Guo, J. Lu, A. Subramanian, and G. E. Sonenshein
Microarray-Assisted Pathway Analysis Identifies Mitogen-Activated Protein Kinase Signaling as a Mediator of Resistance to the Green Tea Polyphenol Epigallocatechin 3-Gallate in Her-2/neu-Overexpressing Breast Cancer Cells.
Cancer Res., May 15, 2006; 66(10): 5322 - 5329.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Lev-Ari, L. Strier, D. Kazanov, L. Madar-Shapiro, H. Dvory-Sobol, I. Pinchuk, B. Marian, D. Lichtenberg, and N. Arber
Celecoxib and Curcumin Synergistically Inhibit the Growth of Colorectal Cancer Cells
Clin. Cancer Res., September 15, 2005; 11(18): 6738 - 6744.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J.-E. Huh, E.-O. Lee, M.-S. Kim, K.-S. Kang, C.-H. Kim, B.-C. Cha, Y.-J. Surh, and S.-H. Kim
Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways
Carcinogenesis, August 1, 2005; 26(8): 1436 - 1445.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Qanungo, M. Das, S. Haldar, and A. Basu
Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells
Carcinogenesis, May 1, 2005; 26(5): 958 - 967.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Shimizu, A. Deguchi, J. T.E. Lim, H. Moriwaki, L. Kopelovich, and I. B. Weinstein
(-)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells
Clin. Cancer Res., April 1, 2005; 11(7): 2735 - 2746.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
C. M. Ardies
Inflammation as Cause for Scar Cancers of the Lung
Integr Cancer Ther, September 1, 2003; 2(3): 238 - 246.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Hsu, W. B. Bollag, J. Lewis, Q. Huang, B. Singh, M. Sharawy, T. Yamamoto, and G. Schuster
Green Tea Polyphenols Induce Differentiation and Proliferation in Epidermal Keratinocytes
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 29 - 34.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. A. Orner, W.-M. Dashwood, C. A. Blum, G. D. Diaz, Q. Li, and R. H. Dashwood
Suppression of tumorigenesis in the Apcmin mouse: down-regulation of {beta}-catenin signaling by a combination of tea plus sulindac
Carcinogenesis, February 1, 2003; 24(2): 263 - 267.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. Chen, X. Yang, H. Jiao, and B. Zhao
Tea Catechins Protect against Lead-Induced Cytotoxicity, Lipid Peroxidation, and Membrane Fluidity in HepG2 Cells
Toxicol. Sci., September 1, 2002; 69(1): 149 - 156.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Zhang, C. W. Binns, and A. H. Lee
Tea Consumption and Ovarian Cancer Risk: A Case-Control Study in China
Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 713 - 718.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. Yang, H. S. Oz, S. Barve, W. J. S. de Villiers, C. J. McClain, and G. W. Varilek
The Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate Blocks Nuclear Factor-kappa B Activation by Inhibiting Ikappa B Kinase Activity in the Intestinal Epithelial Cell Line IEC-6
Mol. Pharmacol., September 1, 2001; 60(3): 528 - 533.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. S. Yang, J. Y. Chung, G.-y. Yang, S. K. Chhabra, and M.-J. Lee
Tea and Tea Polyphenols in Cancer Prevention
J. Nutr., February 1, 2000; 130(2): 472 - 472.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
T. E. Crew, D. J.E. Elder, and C. Paraskeva
A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate
Carcinogenesis, January 1, 2000; 21(1): 69 - 77.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.